e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

12.95 -0.51 (-3.79%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

34 35 Next >

Mind Medicine: Q1 Earnings Insights ↗

May 16, 2022

Mind Medicine (NASDAQ:MNMD) reported its Q1 earnings results on Monday, May 16, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

2 Of The 5 Cannabis Categories Advanced Slightly During Second Week Of May ↗

May 14, 2022

The cannabis sector consists of 5 distinct categories, each performing differently from the other. Here, the stock performances during the second week of May, YTD and from the 2021 peak.

Via Talk Markets

Psychedelic Compounds-Based Stocks Index Imploding ↗

May 14, 2022

Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high.

Via Talk Markets

Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 13, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94

Via Benzinga

Earnings Preview For Mind Medicine ↗

May 13, 2022

Mind Medicine (NASDAQ:MNMD) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Mind Medicine...

Via Benzinga

Psychedelic Stock Gainers And Losers From May 12, 2022 ↗

May 12, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06

Via Benzinga

Can LSD Treat Anxiety? MindMed's New Topline Data Show Promise, Here's The Research ↗

May 12, 2022

MindMed (NASDAQ: MNMD) researchers shared topline clinical results for a Phase 2 LSD clinical study at the recent Psych Symposium, which was co-sponsored by University Hospital Basel (UHB).

Via Benzinga

Psychedelic Stock Gainers And Losers From May 11, 2022 ↗

May 11, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS:

Via Benzinga

Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗

May 10, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26

Via Benzinga

EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space ↗

May 10, 2022

The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”...

Via Benzinga

Psychedelic Stock Gainers And Losers From May 9, 2022 ↗

May 09, 2022

GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34

Via Benzinga

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More ↗

May 09, 2022

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...

Via Benzinga

Psychedelic Stocks Continue To Decline In May ↗

May 08, 2022

The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.

Via Talk Markets

All 5 Cannabis Categories Declined During The Week Ending May 6th ↗

May 07, 2022

The 5 distinct categories that make up the cannabis sector performed quite differently from each other during the first week of May.

Via Talk Markets

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 06, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Via Benzinga

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

May 05, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Via Benzinga

Wake-Up Call: This Biotech Company Is Using Psychedelics To Treat Addiction ↗

May 05, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 04, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022 ↗

May 04, 2022

Upgrades

Via Benzinga

Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 03, 2022

GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 02, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Via Benzinga

Transcript: Jason Raznick's Conversation with Mr. Wonderful Kevin O'Leary At The Benzinga Psychedelics Conference ↗

May 02, 2022

On this special edition of the RazReport, Benzinga Founder & CEO Jason Raznick sits down with Kevin O'Leary AKA Mr. Wonderful at the Benzinga Psychedelics Capital...

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

April 29, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:

Via Benzinga

Landmark Gathering Of Psychedelics Executives And Scientists To Take Place In London May 11 ↗

April 28, 2022

As the field of psychedelic medicine moves forward and international borders begin to open up, an expanding offering of conferences and live events are becoming available for investors, industry people...

Via Benzinga

Psychedelic Stock Gainers And Losers From April 28, 2022 ↗

April 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20

Via Benzinga

Oregon to Become the First State to Legally Roll Out Psilocybin

April 28, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...

Via FinancialNewsMedia

Topics Derivatives ETFs

Psychedelic Stock Gainers And Losers From April 27, 2022 ↗

April 27, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28

Via Benzinga

EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences ↗

April 27, 2022

Benzinga, a large content provider to brokerages and news outlets, hosts live conferences to recognize disruptive innovation in finance and technology, trading, and emerging...

Via Benzinga

Psychedelic Stock Gainers And Losers From April 26, 2022 ↗

April 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy